Company intelligence / Profile preview
Medicovestor, Inc.
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
Overview
Medicovestor has developed proprietary ADC platforms that functionally increase tumor antigen density to improve treatment efficacy even in tumors with low antigen expression. Their lead programs target ovarian and pancreatic cancers using these novel platforms. The company recently completed an oversubscribed Seed financing round supporting advancement toward clinical trials. They have also secured multiple patents strengthening their intellectual property around their dimeric ADC technology and unique human antibodies[2][6][7].
- Therapeutic areas
- OncologyImmunology
- Modalities
- Antibody Drug Conjugates (ADCs), including dimeric IgG1 ADCs and synergistic combination ADCs with dual payload conjugationHuman antibodies targeting novel antigens for oncology and autoimmune diseases
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Medicovestor, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medicovestor, Inc..